Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Martha L Arango-Rodríguez"'
Autor:
Martha L. Arango-Rodríguez, Ligia C. Mateus, Claudia L. Sossa, Silvia M. Becerra-Bayona, Víctor Alfonso Solarte-David, Miguel Enrique Ochoa Vera, Lady T. Giratá Viviescas, Ana M. Vera Berrio, Sergio Eduardo Serrano, Oliverio Vargas, Andrés Catalá Isla, Alape Benitez, Germán Rangel
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Background Chronic limb-threatening ischemia (CLTI) represents the final stage of peripheral arterial disease. Approximately one-third of patients with CLTI are not eligible for conventional surgical treatments. Furthermore, patients with ad
Externí odkaz:
https://doaj.org/article/7f8678c3c4704e9ab64196e44ee4b9fa
Autor:
Laura V. Lozano Navarro, Xueyi Chen, Lady Tatiana Giratá Viviescas, Andrea K. Ardila-Roa, Maria L. Luna-Gonzalez, Claudia L. Sossa, Martha L. Arango-Rodríguez
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-17 (2022)
Abstract Peripheral arterial disease is atherosclerotic occlusive disease of the lower extremity arteries and afflicts hundreds of millions of individuals worldwide. Its most severe manifestation is chronic limb-threatening ischemia (Petersen et al.
Externí odkaz:
https://doaj.org/article/8574988c404e4738a1dcf1615cdefb6a
Autor:
Silvia M Becerra-Bayona, Víctor Alfonso Solarte-David, Claudia L Sossa, Ligia C Mateus, Martha Villamil, Jorge Pereira, Martha L Arango-Rodríguez
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-7 (2020)
Diabetic foot ulcer morbidity and mortality are dramatically increasing worldwide, reinforcing the urgency to propose more effective interventions to treat such a devastating condition. Previously, using a diabetic mouse model, we demonstrated that a
Externí odkaz:
https://doaj.org/article/83af05ada56e4cb1bcf6defc67ee1993
Autor:
Víctor Alfonso Solarte David, Viviana Raquel Güiza-Argüello, Martha L. Arango-Rodríguez, Claudia L. Sossa, Silvia M. Becerra-Bayona
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
The absence or damage of a tissue is the main cause of most acute or chronic diseases and are one of the appealing challenges that novel therapeutic alternatives have, in order to recover lost functions through tissue regeneration. Chronic cutaneous
Externí odkaz:
https://doaj.org/article/32b9cbfce1a147ae96a8d3d084f89ed0
Autor:
Juan D. Arias, Carlos M. Córdoba-Ortega, Dayron F. Martinez-Pulgarin, Carlos M. Rangel, Martha L. Arango-Rodríguez
Publikováno v:
Highlights of Vitreoretina. 16:23-31
Autor:
Martha L. Arango-Rodríguez, Víctor Alfonso Solarte-David, Silvia M. Becerra-Bayona, Eduardo Callegari, Maria D. Paez, Claudia L. Sossa, Miguel Enrique Ochoa Vera, Ligia C. Mateus, Sergio Eduardo serrano, Andrea K. Ardila-Roa, Lady T. Giratá Viviescas
Publikováno v:
Cytotherapy. 24:1035-1048
Diabetes-related foot complications have been identified as the most common isolated cause of morbidity among patients with diabetes and the leading cause of amputation. Therefore, new strategies to stimulate skin regeneration may provide a novel the
Autor:
Martha L Arango-Rodríguez, Ligia C Mateus, Claudia L Sossa, Silvia M Becerra, Víctor Alfonso Solarte-David, Miguel Enrique Ochoa Vera, Lady T Giratá Viviescas, Ana M Vera Berrio, Sergio Eduardo Serrano, Oliverio Vargas, Andrés Catalá Isla, Alapé Benitez, Germán Rangel
Background Chronic limb-threatening ischemia (CLTI) represents the final stage of peripheral arterial disease. Approximately one-third of patients with CLTI are not eligible for conventional surgical treatments. Furthermore, patients with advanced-st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9898ebac60623b74b26d0be645e68f2a
https://doi.org/10.21203/rs.3.rs-2334919/v1
https://doi.org/10.21203/rs.3.rs-2334919/v1
The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice.
Autor:
Tomas de Mayo, Paulette Conget, Silvia Becerra-Bayona, Claudia L Sossa, Virgilio Galvis, Martha L Arango-Rodríguez
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0177533 (2017)
Mesenchymal stromal cells (MSCs) have shown to be a promising tool in cell therapies to treat different conditions. Several pre-clinical and clinical studies have proved that the transplantation of MSCs improves wound healing. Here, we compare the be
Externí odkaz:
https://doaj.org/article/6f69dc49d05741cb9d7a8fe54fa6f303
Autor:
Flavia Bruna, David Contador, Paulette Conget, Benjamín Erranz, Claudia L. Sossa, Martha L. Arango-Rodríguez
Publikováno v:
Stem Cells International, Vol 2016 (2016)
Preclinical and clinical studies have shown that a therapeutic effect results from mesenchymal stromal cells (MSCs) transplant. No systematic information is currently available regarding whether donor age modifies MSC regenerative potential on cutane
Externí odkaz:
https://doaj.org/article/7864ac068c604723a7c90766a4a540ed
Autor:
Ligia C Mateus, Víctor Alfonso Solarte-David, Martha L. Arango-Rodríguez, Jorge Pereira, Claudia Sossa, Silvia Becerra-Bayona, Martha Villamil
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-7 (2020)
Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports
Summary Diabetic foot ulcer morbidity and mortality are dramatically increasing worldwide, reinforcing the urgency to propose more effective interventions to treat such a devastating condition. Previously, using a diabetic mouse model, we demonstrate